BioSpace News Archive

Nanoparticle drug delivery is an emerging field of life science that promises to revolutionize the field of medicine and medical technology.

Any kind of surgeries involve a variety of different components and apparatus. One of the most common medical device used by doctors and surgeons is the surgical sutures. Sutures help to hold the wounded body tissues together.

Life Sciences British Columbia (LSBC) announces the companies presenting at the first annual Invest in the West presented by Amplitude Ventures on March 10, 2022.

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced that it has received U.S. Food and Drug Administration approval for its fifth ADMA BioCenters plasma collection facility located in Conyers, Georgia.

electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will be presenting at the 34th Annual Roth Conference.

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and Shaeffer Bannigan to Vice President, Product Development, Spinal Implants.

TELA Bio, Inc. (“TELA”) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced that it will release its fourth quarter and full year 2021 financial results on Monday, March 21, 2022.

Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics plc (“Adaptimmune”), has joined its board of directors.

Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the fourth quarter and full year 2021 on Monday, March 21, 2022, after market close.

Amgen announced the groundbreaking of its newest biomanufacturing facility, located in Holly Springs, North Carolina.